{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-25-125451","form_type":"8-K","ticker":"APTN","cik":"0001938571","company_name":"ADAPTIN BIO, INC.","filed_at":"2025-12-23T23:59:59+00:00","discovered_at":"2026-05-14T18:02:41.111018+00:00","generated_at":"2026-05-16T12:19:44.248591+00:00","sec_items":["1.01","3.02"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.45,"calibrated_materiality_score":0.45,"confidence":"high","headline":"Adaptin Bio raises $1M in private placement of 200,000 shares at $5.00 each","bullets":["Gross proceeds of $1.0 million from sale of 200,000 shares at $5.00 per share in a private placement.","Placement agent receives 10% cash commission and warrants for 10% of shares sold, exercisable at $5.00 for 5 years.","Company will file resale registration statement; 12% per annum penalty for registration delays.","Holders get piggyback registration rights subject to underwriter cut-back on a pro rata basis."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-25-125451","json":"https://secwatch.observer/filing/0001213900-25-125451.json","markdown":"https://secwatch.observer/filing/0001213900-25-125451.md","text":"https://secwatch.observer/filing/0001213900-25-125451.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1938571/000121390025125451/0001213900-25-125451-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1938571/000121390025125451/ea0270605-8k_adaptin.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T12:19:44.248591+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"d92d7709a2cba78959e0c0f0bea2a67c063fb8ce","claim":"ADAPTIN BIO, INC. issued 200,000 shares of common stock to certain investors for $5.00 per Share for gross proceeds of $1.0 million.","evidence_excerpt":"On December 22, 2025, Adaptin Bio, Inc. (the “Company”) entered into a subscription agreement (the “Subscription Agreement”) with certain investors and sold 200,000 shares (the “Shares”) of the Company’s common stock (the “Common Stock”) at $5.00 per Share for gross proceeds of $1.0 million in a closing of a private placement offering (the “Offering”).","evidence_source":"SEC 8-K Item 3.02/3.03","evidence_url":"https://www.sec.gov/Archives/edgar/data/1938571/000121390025125451/0001213900-25-125451-index.htm","confidence":0.9,"family_label":"Equity Issuances","details":[{"label":"Security","value":"common stock"},{"label":"Shares","value":"200,000 shares"},{"label":"Purchaser","value":"certain investors"},{"label":"Consideration","value":"$5.00 per Share for gross proceeds of $1.0 million"}],"fact_type":"equity_issuance"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}